NLS Pharmaceutics
NLSP
NLSP
7 hedge funds and large institutions have $4.35M invested in NLS Pharmaceutics in 2023 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 3 closing their positions.
Holders
7
Holders Change
-2
Holders Change %
-22.22%
% of All Funds
0.11%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
1
Reduced
2
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Wells Fargo
San Francisco,
California
|
$39.6K |
| 2 |
JGC
2
J. Goldman & Co
New York
|
$178K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
BI
1
BVF Inc
San Francisco,
California
| $3.97M | – | – | – |
|
|
JGC
2
J. Goldman & Co
New York
| $178K | +$35.2K | +1,257 | +25% |
|
|
AAA
3
Affinity Asset Advisors
New York
| $140K | -$140K | -4,989 | -50% |
|
|
4
Wells Fargo
San Francisco,
California
| $39.6K | +$39.6K | +1,414 | New |
|
5
Renaissance Technologies
New York
| $15K | -$23.9K | -840 | -61% |
|
6
Geode Capital Management
Boston,
Massachusetts
| $9.92K | – | – | – |
|
7
Bank of America
Charlotte,
North Carolina
| $63 | – | – | – |
|
|
TSS
8
Two Sigma Securities
New York
| – | -$40.8K | -927 | Closed |
|
9
UBS Group
Zurich,
Switzerland
| – | -$3.75K | -85 | Closed |
|
|
TRCT
10
Tower Research Capital (TRC)
New York
| – | -$110 | -3 | Closed |
|